D-1094-2017 Class III Terminated
FDA drug recall D-1094-2017 was initiated by AVKARE Inc. on Jul 19, 2017 and is designated Class III. Reason for recall: Failed impurities/degradation specifications: Out of specification for a related compound C. The recall status is terminated (terminated Mar 11, 2019). Affected quantity: 1172 cartons (23440 tablets).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 23, 2017
- Initiation Date
- Jul 19, 2017
- Termination Date
- Mar 11, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1172 cartons (23440 tablets)
Product description
Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12
Reason for recall
Failed impurities/degradation specifications: Out of specification for a related compound C.
Distribution pattern
Nationwide
Code information
Lot #: 16933, Exp 07/2018; 17054, Exp 08/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1094-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026